Invention Grant
- Patent Title: Single-chain insulin agonists exhibiting high activity at the insulin receptor
-
Application No.: US14563362Application Date: 2014-12-08
-
Publication No.: US09458220B2Publication Date: 2016-10-04
- Inventor: Richard D. DiMarchi , Yulia Azriel , Zachary Kaur , Jonathan Meyers , Todd Parody , Yan Zhao
- Applicant: Indiana University Research and Technology Corporation
- Applicant Address: US IN Indianapolis
- Assignee: Indiana University Research and Technology Corporation
- Current Assignee: Indiana University Research and Technology Corporation
- Current Assignee Address: US IN Indianapolis
- Agency: Barnes & Thornburg LLP
- Main IPC: C07K14/62
- IPC: C07K14/62 ; A61K38/28 ; A61K47/48 ; A61K38/00

Abstract:
Single chain insulin analogs are provided having high potency and specificity for the insulin receptor. As disclosed herein optimally sized linking moieties can be used to link human insulin A and B chains, or analogs or derivatives thereof, wherein the carboxy terminus of the B25 amino acid of the B chain is linked to the amino terminus of the A1 amino acid of the A chain via the intervening linking moiety. In on embodiment the linking moiety comprises a polyethylene glycol of 6-16 monomer units and in an alternative embodiment the linking moiety comprises a non-native amino acid sequence derived form the IGF-1 C-peptide and comprising at least 8 amino acids and no more than 12 amino acid in length. Also disclosed are prodrug and conjugate derivatives of the single chain insulin analogs.
Public/Granted literature
- US20150148520A1 SINGLE-CHAIN INSULIN AGONISTS EXHIBITING HIGH ACTIVITY AT THE INSULIN RECEPTOR Public/Granted day:2015-05-28
Information query